Images are for illustration purposes only. Packaging may change from time to time and images on our website may or may not be updated.
For active immunisation of breeding females from farms affected with European (genotype 1) Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) to reduce the duration of viraemia, the proportion of viraemic gilts/sows and viral loads in blood after exposure to PRRSV as shown under experimental conditions. Onset of immunity : 4 weeks Duration of immunity :17 weeks Vaccination of breeding females according to the recommended schedule described below reduces the negative reproductive disorders associated with PRRSV. Under experimental challenge conditions a reduction in transplacental virus transmission after challenge was additionally demonstrated. In piglets from vaccinated sows, a reduction in the negative impact of PRRS virus infection (mortality, clinical signs and weight gain) was also demonstrated during the first 20 days of life.
All prices include VAT where applicable.
Only verified purchasers of this product can leave a review.
There are currently no questions for ReproCyc PRRS EU - be the first to ask one!